As the FDA warns consumers to stop using Hydroxycut products, a new editorial published in the May 2009 issue of The FASEB Journal shows that this FDA warning is not unique. In the editorial, Gerald Weissmann, M.D. Editor-in-Chief of the journal and Research Professor of Medicine and Director of the Biotechnology Study Center at NYU School of Medicine, examines litigation involving StarCaps dietary supplement weight loss capsules to illustrate regulatory loopholes that make it impossible for the FDA to prevent dangerous substances sold with health claims from reaching the market.


read more>>


Follow  

How much of your time would you estimate you spend growing your business?